[go: up one dir, main page]

ES2046270T3 - Un procedimiento para fabricar una composicion farmaceutica en forma de una tableta de compresion multiple. - Google Patents

Un procedimiento para fabricar una composicion farmaceutica en forma de una tableta de compresion multiple.

Info

Publication number
ES2046270T3
ES2046270T3 ES198888116540T ES88116540T ES2046270T3 ES 2046270 T3 ES2046270 T3 ES 2046270T3 ES 198888116540 T ES198888116540 T ES 198888116540T ES 88116540 T ES88116540 T ES 88116540T ES 2046270 T3 ES2046270 T3 ES 2046270T3
Authority
ES
Spain
Prior art keywords
formulation
pharmaceutical composition
multiple compression
procedure
manufacturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888116540T
Other languages
English (en)
Inventor
Norval E. Webb
Gregory V. Hammer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2046270T3 publication Critical patent/ES2046270T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSICION FARMACEUTICA EN FORMA DE COMPRIMIDOS POR COMPRESION MULTIPLE QUE COMPRENDE: A) UNA ZONA DISCRETA HECHA CON UNA FORMULACION A QUE CONTIENE UN MATERIAL BASE COMO VEHICULO COMBINADO CON UNA CANTIDAD DE DESCONGESTIVO TERAPEUTICAMENTE EFICAZ DE UN SIMPATOMIMETICO, O UNA SAL SUYA FARMACEUTICAMENTE ACEPTABLE, SIENDO EL VEHICULO UNA MEZCLA DE UNO O MAS ETERES CELULOSICOS EN CANTIDAD ENTRE 18 Y 50% EN PESO CON RESPECTO A LA FORMULACION A, DE 2 A 20% DE UNO O MAS TENSIOACTIVOS ANIONICOS FARMACEUTICAMENTE ACEPTABLES Y UNO O MAS EXCIPIENTES, Y B) UNA ZONA DISCRETA DE UNA FORMULACION B QUE LLEVA UN SEGUNDO VEHICULO COMBINADO CON UN ANTIBITAMINICO DE UN PIPERIDINO - ALCANOL O UNA SAL SUYA, SIENDO EL SEGUNDO VEHICULO UNA MEZCLA DE 0.5 A 25% EN PESO DE CARBONATO CALCICO CON RESPECTO A LA FORMULACION B, DE 1 A 10% EN PESO DE UNO O MAS TENSIOACTIVOS NO IONICOS Y UNO O MAS DE OTROS EXCIPIENTES, CON LA CONDICION DE QUE EL COMPRIMIDO TENGA EN EL NUCLEO LA FORMULACION A Y EN LA ZONA EXTERIOR LA FORMULACION B.
ES198888116540T 1987-10-07 1988-10-06 Un procedimiento para fabricar una composicion farmaceutica en forma de una tableta de compresion multiple. Expired - Lifetime ES2046270T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10593987A 1987-10-07 1987-10-07
US21130888A 1988-06-24 1988-06-24

Publications (1)

Publication Number Publication Date
ES2046270T3 true ES2046270T3 (es) 1994-02-01

Family

ID=26803117

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888116540T Expired - Lifetime ES2046270T3 (es) 1987-10-07 1988-10-06 Un procedimiento para fabricar una composicion farmaceutica en forma de una tableta de compresion multiple.

Country Status (18)

Country Link
EP (1) EP0311067B1 (es)
JP (1) JP2722219B2 (es)
KR (1) KR960007748B1 (es)
CN (1) CN1053570C (es)
AU (1) AU608069B2 (es)
CA (1) CA1314485C (es)
DE (1) DE3874072T2 (es)
DK (1) DK168270B1 (es)
ES (1) ES2046270T3 (es)
FI (1) FI89241C (es)
GR (1) GR3005542T3 (es)
HU (1) HU200916B (es)
IE (1) IE61130B1 (es)
IL (1) IL87943A (es)
NO (1) NO176746C (es)
NZ (1) NZ226482A (es)
PH (1) PH26155A (es)
PT (1) PT88682B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
CZ284822B6 (cs) * 1993-06-14 1999-03-17 Janssen Pharmaceutica N. V. Tableta a způsob její výroby
WO1996026726A1 (en) * 1995-02-28 1996-09-06 Hoechst Marion Roussel, Inc. Pharmaceutical composition for piperidinoalkanol compounds
CA2217233A1 (en) * 1995-04-03 1996-10-10 Chugai Seiyaku Kabushiki Kaisha Sucralfate containing pharmaceutical composition
EP0811374A1 (en) 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
UA60335C2 (uk) * 1997-08-26 2003-10-15 Хехст Маріон Рассел, Інк. Фармацевтична композиція, яка об'єднує піперидиноалканол з протинабряковим агентом
US6194431B1 (en) 1998-04-14 2001-02-27 Paul D. Rubin Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
US6232351B1 (en) * 1998-05-22 2001-05-15 Amway Corporation Co-processed botanical plant composition
US6267986B1 (en) * 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
US20020094345A1 (en) 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
EP2121031B1 (en) * 2007-03-12 2013-10-16 Nektar Therapeutics Oligomer-antihistamine conjugates

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions
US3878217A (en) 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US4285957A (en) 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
US4254129A (en) 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
JPS5788117A (en) * 1980-11-21 1982-06-01 Smithkline Corp Gelatin capsule containing triamterene
JPS5877810A (ja) * 1981-11-01 1983-05-11 Taiho Yakuhin Kogyo Kk ポリグリセロ−ル不飽和脂肪酸エステルを含む経口薬剤組成物
IT1198386B (it) * 1982-07-06 1988-12-21 Lepetit Spa Un prodotto a rilascio protratto contenente il suloctidile
ZA838033B (en) * 1982-11-01 1984-06-27 Merrell Dow Pharma Sustained release solid dosage forms having non-uniform distribution of active ingredient
IL70071A (en) * 1982-11-01 1987-12-31 Merrell Dow Pharma Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient
GB2142824B (en) * 1983-07-07 1987-02-11 American Home Prod Pharmaceutical composition containing a liquid lubricant

Also Published As

Publication number Publication date
NZ226482A (en) 1990-09-26
IE883033L (en) 1989-04-07
DK559088D0 (da) 1988-10-06
DK559088A (da) 1989-04-08
AU608069B2 (en) 1991-03-21
IL87943A0 (en) 1989-03-31
CA1314485C (en) 1993-03-16
JPH01128925A (ja) 1989-05-22
KR890006236A (ko) 1989-06-12
PT88682A (pt) 1988-11-01
HU200916B (en) 1990-09-28
DK168270B1 (da) 1994-03-07
AU2345988A (en) 1989-04-20
PT88682B (pt) 1992-12-31
EP0311067A1 (en) 1989-04-12
JP2722219B2 (ja) 1998-03-04
FI89241B (fi) 1993-05-31
FI89241C (fi) 1993-09-10
NO884443L (no) 1989-04-10
IE61130B1 (en) 1994-10-05
NO176746B (no) 1995-02-13
FI884545A0 (fi) 1988-10-03
CN1032738A (zh) 1989-05-10
NO176746C (no) 1995-05-24
DE3874072D1 (de) 1992-10-01
EP0311067B1 (en) 1992-08-26
HUT48816A (en) 1989-07-28
FI884545A (fi) 1989-04-08
GR3005542T3 (es) 1993-06-07
IL87943A (en) 1992-02-16
CN1053570C (zh) 2000-06-21
NO884443D0 (no) 1988-10-06
KR960007748B1 (ko) 1996-06-12
PH26155A (en) 1992-03-18
DE3874072T2 (de) 1993-04-08

Similar Documents

Publication Publication Date Title
ES2032755T3 (es) Medicamentos conteniendo hexadecil-fosfocolina con efecto antitumoral.
ES2032860T3 (es) Adsorbatos medicamentosos con surfactante y su preparacion.
ES2046270T3 (es) Un procedimiento para fabricar una composicion farmaceutica en forma de una tableta de compresion multiple.
ES2152986T3 (es) Genoterapia de celulas mesoteliales.
ES2054813T3 (es) Formulacion de acetaminofen de liberacion sostenida por via oral y procedimiento para obtenerla.
ES2060737T3 (es) Procedimiento de preparacion de un granulado farmaceutico.
ECSP941148A (es) Medicamento en forma de comprimido con liberacion retardada de substancia activa
ES8503508A1 (es) Una forma de dosificacion unitaria farmaceutica
SE8303531D0 (sv) Farmaceutisk komposition
SE8202172L (sv) Topiska farmaceutiska kompositioner
AR013947A1 (es) Composicion farmaceutica para combinacion de piperidinoalcanol- descongestionante
AR246012A1 (es) Metodo para producir tabletas de colestiramina directamente comprimidas que poseen un revestimiento libre de solventes.
ATE66368T1 (de) Sich schnell verfluessigende kautablette.
MX9308188A (es) Glucomanano de konjac facilmente disponible, como un excipiente de liberacion sostenida.
CO4940406A1 (es) Composiciones de paracetamol de accion rapida
ES2096788T3 (es) Frasco cuentagotas para dos productos que se han de mezclar con anterioridad a su uso.
GB1484832A (en) Tablets
ES269650A1 (es) Procedimiento para la fabricaciën de comprimidos
CO5540295A2 (es) Comprimido para tragar que comprende paracetamol
ES2098930T3 (es) Micropastillas de retardo de derivados de beta-fenilpropiofenona.
GB993291A (en) Tablets, pills, pellets and the like
ES2014518A6 (es) Procedimiento para la produccion de una composicion farmaceutica de liberacion retardada.
ES480113A1 (es) Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
ES2051809T3 (es) Un procedimiento para preparar una composicion farmaceutica.
GB2021409A (en) Pharmaceutical composition

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 311067

Country of ref document: ES